1. Home
  2. VRA vs CELU Comparison

VRA vs CELU Comparison

Compare VRA & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$3.29

Market Cap

94.5M

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.25

Market Cap

35.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
CELU
Founded
1982
2016
Country
United States
United States
Employees
N/A
123
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.5M
35.2M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
VRA
CELU
Price
$3.29
$1.25
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
437.2K
104.5K
Earning Date
06-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$416,097,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.61
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$1.01
52 Week High
$3.70
$4.35

Technical Indicators

Market Signals
Indicator
VRA
CELU
Relative Strength Index (RSI) 63.30 48.66
Support Level $1.93 $1.21
Resistance Level $3.33 $1.33
Average True Range (ATR) 0.22 0.11
MACD 0.08 0.00
Stochastic Oscillator 69.23 49.99

Price Performance

Historical Comparison
VRA
CELU

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: